Dysregulation of Neuropeptide and Tau Peptide Signatures in Human Alzheimer’s Disease Brain

[Image: see text] Synaptic dysfunction and loss occur in Alzheimer’s disease (AD) brains, which results in cognitive deficits and brain neurodegeneration. Neuropeptides comprise the major group of synaptic neurotransmitters in the nervous system. This study evaluated neuropeptide signatures that are...

Descripción completa

Detalles Bibliográficos
Autores principales: Podvin, Sonia, Jiang, Zhenze, Boyarko, Ben, Rossitto, Leigh-Ana, O’Donoghue, Anthony, Rissman, Robert A., Hook, Vivian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2022
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9264367/
https://www.ncbi.nlm.nih.gov/pubmed/35758417
http://dx.doi.org/10.1021/acschemneuro.2c00222

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9264367/
https://www.ncbi.nlm.nih.gov/pubmed/35758417
http://dx.doi.org/10.1021/acschemneuro.2c00222

Ejemplares similares